title: Evaluation of a Pharmacist-Specific Intervention on 30-Day Readmission Rates for High-Risk Patients with Pneumonia.
abstract: BACKGROUND
  Pharmacist interventions have been shown to have an impact on reducing readmission rates, however further research is necessary to target resources to high-risk populations and determine the most effective bundle of interventions.
  
  
  OBJECTIVE
  To evaluate the effect of a pharmacist-bundled intervention on 30-day readmission rates for high-risk patients with pneumonia.
  
  
  METHODS
  A pilot study with a historical control conducted at a community, teaching-affiliated medical center. Up to 65 selected subjects were included if they had pneumonia and any of the following high-risk criteria: admission within 6 months, at least 5 scheduled home medications, chronic obstructive pulmonary disease (COPD), or heart failure. A retrospective chart review was conducted to compile the historical control group that received usual care between June and November 2013. Patients admitted from December 2013 through March 2014 were reviewed to receive a bundled intervention. The primary outcome was 30-day readmission rates. Risk factors and reasons for readmission, pharmacist clinical interventions, and the time interval between discharge and readmission were also evaluated.
  
  
  RESULTS
  A trend toward a reduced 30-day readmission rate was observed in the intervention group (n = 43) compared to those who received usual care (n = 65) (27.9% vs 40.0%; relative risk [RR], 0.6977; 95% CI, 0.3965-1.2278; P = .2119). The most commonly identified high-risk inclusion criteria were having at least 5 scheduled home medications and COPD. The time interval between discharge and readmission did not considerably differ between groups (10.8 vs 10.6 days).
  
  
  CONCLUSIONS
  The pharmacist-bundled intervention was associated with a reduced 30-day readmission rate for high-risk patients with pneumonia.
authors.affiliation: Assistant Clinical Professor, Department of Pharmacy Practice, Auburn University Harrison School of Pharmacy, Auburn, Alabama; Assistant Clinical Professor, Department of Family Medicine, University of Alabama College of Community Health Sciences, University Medical Center, Tuscaloosa, Alabama.
authors.forename: Katelin M
authors.initials: KM
authors.lastname: Lisenby
authors.affiliation: Internal Medicine Clinician and PGY1 Residency Program Director, DCH Regional Medical Center, Tuscaloosa , Alabama.
authors.forename: Douglas N
authors.initials: DN
authors.lastname: Carroll
authors.affiliation: Assistant Clinical Professor, Department of Pharmacy Practice, Auburn University Harrison School of Pharmacy, Auburn, Alabama; Assistant Clinical Professor, Department of Family Medicine, University of Alabama College of Community Health Sciences, University Medical Center, Tuscaloosa, Alabama.
authors.forename: Nathan A
authors.initials: NA
authors.lastname: Pinner
keywords: discharge planning; factors; hospital readmissions; medication reconciliationv; pharmacistv; risk
references.citation: Ann Intern Med. 2009 Feb 3;150(3):178-87
references.pmid: 19189907
references.citation: Mayo Clin Proc. 2005 Aug;80(8):991-4
references.pmid: 16092576
references.citation: J Gen Intern Med. 2005 Apr;20(4):317-23
references.pmid: 15857487
references.citation: J Gen Intern Med. 2010 May;25(5):441-7
references.pmid: 20180158
references.citation: Am J Health Syst Pharm. 2014 May 1;71(9):739-45
references.pmid: 24733137
references.citation: Arch Intern Med. 1999 Sep 13;159(16):1939-45
references.pmid: 10493325
references.citation: Arch Intern Med. 2005 Sep 12;165(16):1842-7
references.pmid: 16157827
references.citation: Hosp Pharm. 2013 May;48(5):380-8
references.pmid: 24421494
references.citation: Arch Intern Med. 2009 May 11;169(9):894-900
references.pmid: 19433702
references.citation: N Engl J Med. 2011 Nov 24;365(21):2002-12
references.pmid: 22111719
references.citation: Drugs Aging. 2009;26(2):123-33
references.pmid: 19220069
references.citation: N Engl J Med. 2009 Apr 2;360(14):1418-28
references.pmid: 19339721
references.citation: AAPPO J. 1993 Apr-May;3(2):33-4, 38-40
references.pmid: 10148619
references.citation: Ann Intern Med. 2011 Oct 18;155(8):520-8
references.pmid: 22007045
references.citation: Br J Clin Pharmacol. 2010 Nov;70(5):749-55
references.pmid: 21039769
references.citation: Prof Case Manag. 2009 May-Jun;14(3):135-40; quiz 141-2
references.pmid: 19474639
references.citation: Arch Intern Med. 2009 Nov 23;169(21):2003-10
references.pmid: 19933963
references.citation: J Hosp Med. 2009 Apr;4(4):211-8
references.pmid: 19388074
references.citation: Arch Intern Med. 2006 Mar 13;166(5):565-71
references.pmid: 16534045
references.citation: J Psychiatr Res. 2011 May;45(5):626-9
references.pmid: 21035130
references.citation: Arch Intern Med. 2006 Sep 25;166(17):1822-8
references.pmid: 17000937
references.citation: Arch Intern Med. 1998 May 25;158(10):1067-72
references.pmid: 9605777